60 second reveal: 3 Regulatory authorities that can make or break your pharma or device sale

Darshan Kulkarni emphasizes that companies considering #acquisitions must be ready for scrutiny from multiple agencies: FDA, FTC, DOJ, and OIG. FDA examines various aspects like manufacturing, clinical research, pharmacovigilance, advertising, and distribution. FTC now addresses advertising and antitrust concerns. DOJ concentrates on corporate compliance. Is your organization well-prepared for these assessments? Get in touch with us for more information. Support the Show.